Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001241322-03-000001
Filing Date
2003-07-09
Accepted
2003-07-09 15:40:25
Documents
1
Period of Report
2003-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 2833
  Complete submission text file 0001241322-03-000001.txt   4547
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 62 GRASMERE STREET NEWTON MA 02458 6172446865
MEADE HARRY (Reporting) CIK: 0001241322 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 03780140